LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹133 Cr | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹101 Cr |
| Mar2022 | ₹90 Cr |
| Mar2021 | ₹88 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹133 Cr | 32.49 | |
| Mar2024 | ₹101 Cr | -0.54 | |
| Mar2023 | ₹101 Cr | 12.27 | |
| Mar2022 | ₹90 Cr | 2.13 | |
| Mar2021 | ₹88 Cr | - | |
Compare Total Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹126.0 Cr | -2.9% | -7.4% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -2.9% |
-7.4% |
-1.4% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses